These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 3311477

  • 21. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [Abstract] [Full Text] [Related]

  • 22. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test?
    Borm K, Slawik M, Seiler L, Flohr F, Petrick M, Honegger J, Reincke M.
    Eur J Endocrinol; 2003 Dec; 149(6):535-41. PubMed ID: 14640994
    [Abstract] [Full Text] [Related]

  • 23. Severe hyponatremia caused by hypothalamic adrenal insufficiency.
    Shibata T, Oeda T, Saito Y.
    Intern Med; 1999 May; 38(5):426-32. PubMed ID: 10397081
    [Abstract] [Full Text] [Related]

  • 24. Role of sampling times and serum cortisol cut-off concentrations on the routine assessment of adrenal function using the standard cosyntropin test in an academic hospital from Spain: a retrospective chart review.
    Ortiz-Flores AE, Santacruz E, Jiménez-Mendiguchia L, García-Cano A, Nattero-Chávez L, Escobar-Morreale HF, Luque-Ramírez M.
    BMJ Open; 2018 May 05; 8(5):e019273. PubMed ID: 29730618
    [Abstract] [Full Text] [Related]

  • 25. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug 05; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 26. Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: an observational study.
    Miyauchi T, Tsuruta R, Fujita M, Kaneko T, Kasaoka S, Maekawa T.
    BMC Infect Dis; 2009 Dec 21; 9():209. PubMed ID: 20021698
    [Abstract] [Full Text] [Related]

  • 27. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M, Colak R, Eser C, Ozsoy O, Tutus A, Kelestimur F.
    Clin Endocrinol (Oxf); 2001 Oct 21; 55(4):455-9. PubMed ID: 11678827
    [Abstract] [Full Text] [Related]

  • 28. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    Clin Endocrinol (Oxf); 1995 Sep 21; 43(3):283-90. PubMed ID: 7586596
    [Abstract] [Full Text] [Related]

  • 29. The low-dose (1 microg) cosyntropin test (LDT) for primary adrenocortical insufficiency: Defining the normal cortisol response and report on first patients with Addison disease confirmed with LDT.
    Pura M, Kreze A, Kentos P, Vanuga P.
    Exp Clin Endocrinol Diabetes; 2010 Mar 21; 118(3):151-7. PubMed ID: 19358090
    [Abstract] [Full Text] [Related]

  • 30. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery.
    Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S.
    Eur J Endocrinol; 2010 Mar 21; 162(3):477-82. PubMed ID: 19996199
    [Abstract] [Full Text] [Related]

  • 31. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Dec 21; 73(6):1224-34. PubMed ID: 1659582
    [Abstract] [Full Text] [Related]

  • 32. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 21; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 33. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V.
    J Clin Endocrinol Metab; 2001 Aug 21; 86(8):3545-54. PubMed ID: 11502777
    [Abstract] [Full Text] [Related]

  • 34. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis.
    Rasmuson S, Olsson T, Hagg E.
    Clin Endocrinol (Oxf); 1996 Feb 21; 44(2):151-6. PubMed ID: 8849568
    [Abstract] [Full Text] [Related]

  • 35. The hypothalamic-pituitary-adrenocortical axis in severe falciparum malaria: effects of cytokines.
    Davis TM, Li TA, Tran QB, Robertson K, Dyer JR, Phan TD, Meyer D, Beaman MH, Trinh KA.
    J Clin Endocrinol Metab; 1997 Sep 21; 82(9):3029-33. PubMed ID: 9284738
    [Abstract] [Full Text] [Related]

  • 36. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis.
    Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, Rouatbi S, Monia Z, Ach K.
    Endocr J; 2018 Sep 27; 65(9):935-942. PubMed ID: 29952338
    [Abstract] [Full Text] [Related]

  • 37. MECHANISMS IN ENDOCRINOLOGY: New concepts to further unravel adrenal insufficiency during critical illness.
    Boonen E, Van den Berghe G.
    Eur J Endocrinol; 2016 Jul 27; 175(1):R1-9. PubMed ID: 26811405
    [Abstract] [Full Text] [Related]

  • 38. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Schmidt IL, Lahner H, Mann K, Petersenn S.
    J Clin Endocrinol Metab; 2003 Sep 27; 88(9):4193-8. PubMed ID: 12970286
    [Abstract] [Full Text] [Related]

  • 39. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test.
    Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N.
    Clin Endocrinol (Oxf); 2000 May 27; 52(5):633-40. PubMed ID: 10792344
    [Abstract] [Full Text] [Related]

  • 40. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.
    Abdu TA, Elhadd TA, Neary R, Clayton RN.
    J Clin Endocrinol Metab; 1999 Mar 27; 84(3):838-43. PubMed ID: 10084558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.